Mercator Medical S.A.
MRC.WA · WSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | PLN 145,218 | PLN 143,293 | PLN 147,649 | PLN 144,445 |
| % Growth | 1.3% | -3% | 2.2% | – |
| Cost of Goods Sold | PLN 118,434 | PLN 108,899 | PLN 104,080 | PLN 103,321 |
| Gross Profit | PLN 26,784 | PLN 34,394 | PLN 43,569 | PLN 41,124 |
| % Margin | 18.4% | 24% | 29.5% | 28.5% |
| R&D Expenses | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| G&A Expenses | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| SG&A Expenses | PLN 0 | PLN 0 | PLN 28,867 | PLN 36,110 |
| Sales & Mktg Exp. | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Other Operating Expenses | PLN 41,409 | PLN 48,889 | PLN 15,728 | -PLN 17,924 |
| Operating Expenses | PLN 41,409 | PLN 48,889 | PLN 44,595 | PLN 18,186 |
| Operating Income | PLN 618 | -PLN 13,186 | -PLN 1,026 | PLN 22,939 |
| % Margin | 0.4% | -9.2% | -0.7% | 15.9% |
| Other Income/Exp. Net | PLN 4,941 | PLN 7,120 | PLN 21,532 | -PLN 10,076 |
| Pre-Tax Income | PLN 5,559 | -PLN 6,066 | PLN 20,506 | PLN 12,863 |
| Tax Expense | PLN 1,105 | PLN 3,161 | -PLN 10,101 | -PLN 7,608 |
| Net Income | PLN 4,727 | -PLN 9,316 | PLN 29,811 | PLN 20,962 |
| % Margin | 3.3% | -6.5% | 20.2% | 14.5% |
| EPS | 0.51 | -1.01 | 3.22 | 2.24 |
| % Growth | 150.5% | -131.4% | 43.7% | – |
| EPS Diluted | 0.51 | -1.01 | 3.22 | 2.24 |
| Weighted Avg Shares Out | 9,246 | 9,269 | 9,269 | 9,362 |
| Weighted Avg Shares Out Dil | 9,246 | 9,269 | 9,269 | 9,362 |
| Supplemental Information | – | – | – | – |
| Interest Income | PLN 3,857 | PLN 3,933 | PLN 3,899 | PLN 4,491 |
| Interest Expense | PLN 482 | PLN 521 | PLN 88 | PLN 0 |
| Depreciation & Amortization | PLN 7,609 | PLN 7,089 | PLN 6,408 | PLN 4,870 |
| EBITDA | PLN 13,171 | PLN 1,544 | PLN 27,002 | PLN 97 |
| % Margin | 9.1% | 1.1% | 18.3% | 0.1% |